Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 408

Wave reaches market with $102m

Biopharmaceutical company Wave Life Sciences has gone public at the middle of its range just nine months after closing its $18m SNBL-led series A round.

Nov 12, 2015

Swrve veers to $30m series C

The Intel-backed mobile marketing company has now raised more than $50m in total, and has acquired data automation platform Adaptive.io.

Nov 11, 2015

HelloFresh freezes IPO plans

Rocket Internet-backed meal delivery service HelloFresh hoped to raise around $332m from an initial public offering.

Nov 10, 2015

Square sets range for possible $400m IPO

The Visa and Starbucks-backed mobile payment company is set to float at a valuation at least 30% less than at its last equity round.

Nov 9, 2015

WuXi PharmaTech checks out of Novira

Johnson & Johnson has agreed to acquire Novira Therapeutics for an undisclosed sum, providing an exit to WuXi PharmaTech, an investor in its $28m series A round.

Nov 9, 2015

GenSight narrows ambitions by postponing IPO

The Novartis-backed eye disease therapy developer set the range last month for an initial public offering sized at up to $65m.

Nov 9, 2015

Kura raises $50m in IPO

Fidelity-backed biopharmaceutical company Kura floated on Nasdaq yesterday and will use proceeds to fund clinical trials.

Nov 6, 2015

China Huarong celebrates $2.3bn IPO

State-owned debt management firm China Huarong Asset Management raises $2.3bn in its IPO, falling short of its $3bn target.

Nov 5, 2015

Baixing to list on Neeq

The classified listings website, spun out of eBay, is seeking a flotation on Chinese stock exchange National Equities Exchange and Quotations.

Nov 2, 2015

Showroomprive raises $282m IPO

Vipshop-backed online fashion retailer Showroomprive floated below its range, selling individual shares at $2.25 below target.

Nov 2, 2015
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here